What AI governance obligations arise from the IRDAI Health Insurance Master Circular 2024 cashless pre-authorization SLA?

IRDAI Master Circular on Health Insurance Business 2024 (IRDAI/HLT/CIR/PRO/84/5/2024, May 29, 2024, effective July 31, 2024) mandates that insurers issue pre-authorization decisions for cashless hospitalization within 1 hour of request, and final discharge authorization within 3 hours. India's health insurance sector processes millions of cashless claims annually — this timeline is operationally impossible without AI-automated pre-authorization rule engines. Every major standalone health insurer (Star Health, Niva Bupa, Care Health, ManipalCigna) and general insurer with health book (HDFC Ergo, ICICI Lombard, New India Assurance) has deployed AI authorization systems to comply. The AI governance obligations embedded in this SLA mandate: (1) System availability SLA: if the AI pre-authorization system is unavailable, the 1-hour clock still runs — insurers must maintain AI system uptime obligations and have fallback human authorization protocols with demonstrably equivalent SLA capability; (2) SLA audit trail: IRDAI can inspect whether the 1-hour SLA was met for any specific claim; the AI system must log the exact timestamp of authorization request receipt and authorization decision issuance — millisecond precision for disputed SLA compliance; (3) Authorization scope accuracy: the AI must correctly identify what is covered under the specific policy for the specific diagnosis — an AI that authorizes beyond or below the policy entitlement creates both a claims leakage risk (over-authorization) and a consumer protection violation (under-authorization creating denial of covered care); (4) Denial explainability: when the AI declines or partially authorizes a pre-authorization request, the policyholder and treating hospital must receive a reason that enables them to either appeal or seek alternative treatment planning — a free-text AI-generated denial reason not mapped to policy terms creates a consumer harm.

What clinical AI governance is required for necessity assessment under India's health insurance regulations?

IRDAI's Health Insurance Master Circular 2024 mandates coverage for modern treatments, AYUSH therapies, mental health conditions (aligned with Mental Healthcare Act 2017), genetic testing, and other clinical categories — each requiring clinical necessity assessment at pre-authorization. AI clinical decision support models used for necessity assessment in Indian health insurance face governance requirements distinct from general AI governance: (1) Clinical protocol alignment: AI necessity assessment models must reflect IRDAI-mandated coverage categories and current clinical treatment guidelines. An AI trained on historical denial patterns may perpetuate outdated medical necessity standards that conflict with the 2024 circular's expanded coverage mandates (mental health, modern treatments) — creating systematic wrongful denials; (2) Specialty calibration: necessity criteria differ substantially across specialties — oncology, orthopedics, psychiatry, obstetrics. An AI necessity model must be validated separately for each specialty; a model with acceptable aggregate accuracy may have systematic errors in psychiatric necessity assessment due to limited training data in this category; (3) Empanelled hospital network AI: the circular requires real-time eligibility verification for cashless hospitalization at empanelled hospitals; the AI matching patient policy entitlements to empanelled hospital capabilities must be updated when either the policy terms change or hospital empanelment status changes; (4) Telemedicine clinical AI: the circular covers telemedicine-linked health insurance products; AI clinical assessment of telemedicine consultation records for claim eligibility requires validation on telemedicine-format clinical data (abbreviated consultation notes, remote vital signs, self-reported symptoms) — distinct from in-person clinical record assessment.

How does the DPDP Act 2023 intersect with AI processing of health data under IRDAI's health insurance regulations?

Health insurance AI operates on the most sensitive category of personal data under India's DPDP Act 2023: health and medical data. The intersection of IRDAI Health Insurance Master Circular 2024 AI obligations and DPDP Act creates a layered compliance requirement: (1) Consent scope for AI processing: a policyholder's consent to health insurance coverage (given to the insurer) covers the primary insurance contract — but does AI processing of health data for fraud detection, clinical necessity assessment, and predictive analytics fall within the originally consented purpose? DPDP Act Section 8(3) purpose limitation requires that personal data be processed only for the purpose for which consent was given. AI fraud detection and predictive risk analytics applied to health data may extend beyond the primary insurance purpose; (2) Data minimisation vs AI feature richness: AI clinical necessity and fraud detection models improve with richer data — more diagnosis codes, more treatment history, more provider network data. DPDP Act Section 8(2) requires data minimisation (only as much data as necessary). The tension between AI model performance (more data is better) and DPDP minimum necessary principle must be resolved in the AI system design; (3) Right to correction: if an AI model processes an inaccurate medical record and generates a denial based on that inaccuracy, the policyholder's DPDP Act right to correction of personal data applies — and the insurer must have a mechanism to correct the underlying record and reprocess the AI assessment; (4) Health data cross-border AI processing: several Indian insurers use AI platforms hosted outside India. DPDP Act restrictions on cross-border data transfer apply to health data — AI models that process Indian policyholders' health data on foreign servers may violate these restrictions and simultaneously conflict with IRDAI's data localization expectations.

What AI governance is required for the 100% cashless claim settlement direction under IRDAI Health Insurance 2024?

IRDAI's Health Insurance Master Circular 2024 states that 'every insurer shall strive towards settlement of all claims on cashless basis' — an aspirational 100% cashless direction that, combined with the 1-hour SLA mandate, makes comprehensive AI automation of the pre-authorization process effectively required. The move toward 100% cashless has three specific AI governance implications beyond the pre-authorization SLA: (1) Reimbursement-to-cashless conversion AI: insurers processing claims via reimbursement route must build AI systems to identify when a claim could have been cashless — because IRDAI's direction requires justification for non-cashless settlement. AI that identifies post-hoc that a specific claim was processed as reimbursement when a cashless option was available creates a governance accountability loop that no IRDAI guidance has defined; (2) Non-empanelled hospital AI assessment: when a policyholder uses a non-empanelled hospital (for which cashless is not available), IRDAI expects the insurer to have facilitated empanelment proactively. AI hospital network analysis — identifying high-utilization hospitals not yet empanelled — is an implied requirement for the 100% cashless direction; (3) Retrospective claims AI: when a policyholder pays out-of-pocket and subsequently claims reimbursement, the AI assessment of the claim must use the same clinical necessity and coverage eligibility logic as the pre-authorization system — creating a consistency requirement between the cashless authorization AI and the reimbursement settlement AI. Inconsistent decisions between the two systems (AI would have authorized the cashless claim pre-hospitalization but denies the reimbursement claim post-hospitalization for the same clinical episode) create consumer protection violations.

AI Governance · IRDAI · Health Insurance · Cashless Authorization · Clinical AI · India BFSI

IRDAI Health Insurance Master Circular 2024 AI Governance: Cashless Pre-Authorization AI 1-Hour SLA, Clinical Necessity AI Audit Trail, Claim Denial Explainability and DPDP Health Data India

IRDAI's Master Circular on Health Insurance Business 2024 (IRDAI/HLT/CIR/PRO/84/5/2024) consolidated 55 prior health insurance circulars and mandated cashless pre-authorization decisions within 1 hour and final discharge authorization within 3 hours. India's health insurance sector processes millions of cashless claims — this SLA is operationally impossible without AI authorization engines. Star Health, Niva Bupa, HDFC Ergo, ICICI Lombard have all deployed AI pre-authorization systems to comply. Zero AI governance framework defined. Zero global competitor coverage.

Zytra Research Team · October 2026 · 11 min read

📖 Part of the India BFSI AI Governance Complete Guide 2026 — RBI, SEBI, IRDAI, NPCI & DPDP in one place.

India's health insurance market — covering approximately 520 million lives through group and individual policies — processes cashless hospitalization claims at a volume that makes human pre-authorization review impossible at speed. IRDAI's Health Insurance Master Circular 2024 (IRDAI/HLT/CIR/PRO/84/5/2024, May 29, 2024) consolidated 55 earlier health insurance circulars and for the first time set hard time-based SLAs for cashless authorization: 1 hour for pre-authorization, 3 hours for discharge authorization. These SLAs are the regulatory mechanism forcing universal AI adoption in health insurance claims processing.

The governance gap is specific and operationally significant: IRDAI mandated the outcome (decisions within SLA) without defining how the AI that delivers those decisions should be governed. Every health insurer in India now operates AI pre-authorization engines under regulatory pressure to maintain SLA compliance — and none has a regulatory framework telling them what AI model governance looks like for this function.

The 1-Hour SLA: Why It Cannot Be Met Without AI

A major standalone health insurer may process 5,000+ cashless pre-authorization requests on a busy day. Each requires: policy eligibility verification (is this specific treatment covered under this specific policy for this specific member?), sum insured adequacy check (is there remaining cover?), network hospital empanelment verification, clinical necessity assessment against IRDAI-mandated coverage categories, and fraud risk scoring against the hospital's claim history. A human team processing 5,000 requests within 1 hour each — across 24 hours — requires 200+ simultaneous processors, which no TPA or insurer operates at scale. The only compliant operating model is AI automation with human escalation for edge cases.

This operational reality creates a governance obligation: when the AI is the primary decision-maker for a function with a 1-hour regulatory SLA, the AI's accuracy, availability, and audit trail are compliance elements, not just operational performance metrics.

Claim Denial Explainability: Consumer Protection Meets AI

When the AI pre-authorization system denies or partially authorizes a cashless request, the treating hospital and policyholder must receive a denial reason sufficient to appeal or redirect care. An AI denial that outputs only a score or a generic "not covered" response does not satisfy IRDAI's policyholder protection obligations. The denial reason must map to a specific policy exclusion, a specific coverage category limitation, or a specific clinical necessity criterion — a level of structured explainability that many AI pre-authorization systems, particularly those deployed in 2022-2023, were not designed to produce.

Health Insurance AI Governance Checklist

☐ 1-hour SLA AI audit trail: timestamped log of authorization request receipt and decision issuance per claim; SLA breach auto-detection and escalation; system availability SLA and human fallback protocol tested
☐ Authorization scope accuracy: AI coverage eligibility model tested against IRDAI-mandated coverage categories (mental health, modern treatments, AYUSH, genetic testing); specialty-specific accuracy validation; policy update propagation to AI within defined SLA
☐ Denial explainability: AI denial outputs map to specific policy exclusions or clinical necessity criteria; free-text AI rationale prohibited without structured code mapping; hospital and policyholder appeal path clearly defined from AI denial output
☐ Clinical necessity model governance: specialty-specific validation (oncology, psychiatry, orthopedics separately); clinical protocol currency review against latest IRDAI coverage mandates; telemedicine format validation
☐ DPDP Act health data compliance: purpose limitation assessment for AI fraud and analytics uses of health data; data minimisation audit for AI model feature inputs; cross-border AI processing assessment; right to correction mechanism for AI-processed claim records
☐ Cashless consistency: reimbursement settlement AI uses same coverage eligibility logic as cashless AI; post-hoc consistency audit between pre-authorization and reimbursement decisions for same clinical episode
☐ IRDAI examination readiness: SLA compliance log, AI system availability records, denial reason audit, clinical model validation status — packaged for IRDAI health insurance inspection